Assessment of metabolic syndrome in infertile women with polycystic ovary syndrome in a rural population of South India: A cross-sectional study.
Hormones.
Hyperandrogenism
Metabolic syndrome
Polycystic ovary syndrome
Journal
International journal of reproductive biomedicine
ISSN: 2476-4108
Titre abrégé: Int J Reprod Biomed
Pays: Iran
ID NLM: 101679102
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
10
10
2020
revised:
27
03
2021
accepted:
10
08
2021
entrez:
1
6
2022
pubmed:
2
6
2022
medline:
2
6
2022
Statut:
epublish
Résumé
Polycystic ovary syndrome (PCOS) is known to be associated with metabolic syndrome (MS). It is characterised by insulin resistance, hyperinsulinemia, dyslipidemia, obesity and hypertension. Data related to MS in infertile women with PCOS are limited in Indian populations. This study aims to compare the prevalence of MS in infertile women with and without PCOS in a rural population in South India. 130 women with PCOS and 130 women without PCOS were enrolled in this cross-sectional study. A detailed history was taken and a physical examination was done for all women. Anthropometric parameters, a glucose tolerance test, fasting glucose / insulin levels, trigylcerides, high-density lipoprotein cholesterol and blood pressure were assessed in all participants. The International Diabetes Federation criteria were applied for assessment of MS. MS was more prevalent in infertile women with PCOS (42.3%) compared to women without PCOS (19.3%). 56.9% of women with PCOS had low high-density lipoprotein cholesterol levels, 46.2% had high triglycerides, 71.5% had a high waist circumference, 31.5% had high blood pressure and 37.7% had high blood glucose levels. 26.0% of the women with PCOS had a healthy weight, and MS was seen in 6.9% of these women. The prevalence of MS was higher in women with PCOS in comparison to women without PCOS. Among the women with PCOS, the prevalence of MS increased with age (
Sections du résumé
Background
UNASSIGNED
Polycystic ovary syndrome (PCOS) is known to be associated with metabolic syndrome (MS). It is characterised by insulin resistance, hyperinsulinemia, dyslipidemia, obesity and hypertension. Data related to MS in infertile women with PCOS are limited in Indian populations.
Objective
UNASSIGNED
This study aims to compare the prevalence of MS in infertile women with and without PCOS in a rural population in South India.
Materials and Methods
UNASSIGNED
130 women with PCOS and 130 women without PCOS were enrolled in this cross-sectional study. A detailed history was taken and a physical examination was done for all women. Anthropometric parameters, a glucose tolerance test, fasting glucose / insulin levels, trigylcerides, high-density lipoprotein cholesterol and blood pressure were assessed in all participants. The International Diabetes Federation criteria were applied for assessment of MS.
Results
UNASSIGNED
MS was more prevalent in infertile women with PCOS (42.3%) compared to women without PCOS (19.3%). 56.9% of women with PCOS had low high-density lipoprotein cholesterol levels, 46.2% had high triglycerides, 71.5% had a high waist circumference, 31.5% had high blood pressure and 37.7% had high blood glucose levels. 26.0% of the women with PCOS had a healthy weight, and MS was seen in 6.9% of these women.
Conclusion
UNASSIGNED
The prevalence of MS was higher in women with PCOS in comparison to women without PCOS. Among the women with PCOS, the prevalence of MS increased with age (
Identifiants
pubmed: 35642189
doi: 10.18502/ijrm.v20i3.10707
pmc: PMC9099363
doi:
Types de publication
Journal Article
Langues
eng
Pagination
161-168Informations de copyright
Copyright © 2022 Kayali et al.
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest.
Références
Metabolism. 2009 May;58(5):714-21
pubmed: 19375597
J Cardiovasc Thorac Res. 2018;10(2):56-69
pubmed: 30116503
Fertil Steril. 2004 Jan;81(1):19-25
pubmed: 14711538
Reprod Health. 2015 Jan 16;12:7
pubmed: 25595199
Gynecol Endocrinol. 2018 Jan;34(1):40-44
pubmed: 28678568
Fertil Steril. 2014 Feb;101(2):530-5
pubmed: 24382375
Fertil Steril. 2008 Mar;89(3):649-55
pubmed: 17543961
Clin Endocrinol (Oxf). 2021 Oct;95(4):531-541
pubmed: 33460482
J Obstet Gynaecol Res. 2008 Feb;34(1):62-6
pubmed: 18226131
Cholesterol. 2011;2011:920983
pubmed: 21687582
Hum Reprod. 2008 Jun;23(6):1431-8
pubmed: 18359783
J Hum Reprod Sci. 2012 Jan;5(1):26-31
pubmed: 22870011
J Biomed Res. 2017 Nov 01;:
pubmed: 29760297
Lancet. 2005 Sep 24-30;366(9491):1059-62
pubmed: 16182882
Gynecol Endocrinol. 2016;32(5):343-53
pubmed: 27052492
Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S243-6
pubmed: 17610984
Indian J Endocrinol Metab. 2012 Jan;16(1):7-12
pubmed: 22276247
Metab Syndr Relat Disord. 2020 Dec;18(10):462-470
pubmed: 32795106
J Pediatr Adolesc Gynecol. 2011 Aug;24(4):223-7
pubmed: 21600812
Rev Bras Ginecol Obstet. 2019 Jan;41(1):37-43
pubmed: 30716785
Exp Clin Endocrinol Diabetes. 2007 Feb;115(2):130-5
pubmed: 17318774
J Cosmet Dermatol. 2020 Nov;19(11):3053-3057
pubmed: 32564506
Gynecol Endocrinol. 2021 Jan;37(1):21-25
pubmed: 32516071
Indian J Med Res. 2019 Oct;150(4):333-344
pubmed: 31823915
Indian J Pediatr. 2012 Jan;79 Suppl 1:S69-73
pubmed: 21769526
Endocrine. 2021 May;72(2):400-410
pubmed: 33442790
Int J Environ Res Public Health. 2021 Feb 22;18(4):
pubmed: 33671739
Eur J Obstet Gynecol Reprod Biol. 2018 May;224:60-65
pubmed: 29550643
Zhonghua Yi Xue Za Zhi. 2005 Dec 7;85(46):3266-71
pubmed: 16409817
Indian J Endocrinol Metab. 2014 May;18(3):364-9
pubmed: 24944933
J Clin Endocrinol Metab. 2005 Apr;90(4):1929-35
pubmed: 15623819
Biol Sex Differ. 2020 Jul 29;11(1):45
pubmed: 32727622